BLPH — Bellerophon Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Bellerophon Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	16.6	9.87	47.6	24.7	6.92
Prepaid Expenses
Total Other Current Assets
Total Current Assets	17.4	10.4	48.1	25.5	7.56
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.664	2.43	1.67	0.93	0.186
Other Long Term Assets
Total Assets	18.4	13.1	50.2	26.9	7.93
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	7.54	7.58	10.4	5.05	5.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	14.5	9.52	12	5.26	5.4
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	3.86	3.59	38.2	21.6	2.53
Total Liabilities & Shareholders' Equity	18.4	13.1	50.2	26.9	7.93
Total Common Shares Outstanding